Fedratinib Induces Spleen Responses In Patients With Myeloproliferative Neoplasm-Associated Intermediate- Or High-Risk Myelofibrosis (Mf) Previously Exposed To Ruxolitinib (Rux), Regardless Of Reason For Discontinuing Rux
BLOOD（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要